US Patent Issued to Jyvaskylan yliopisto on April 14 for "Vemurafenib and salts thereof for use in the treatment of enteroviral infections" (Finnish Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,591, issued on April 14, was assigned to Jyvaskylan yliopisto (Jyvaskylan yliopisto, Finland).

"Vemurafenib and salts thereof for use in the treatment of enteroviral infections" was invented by Varpu Marjomaki (Jyvaskyla, Finland), Mira Laajala (Jyvaskyla, Finland) and Mari Martikainen (Jyvaskyla, Finland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides N-(3-(5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide known as vemurafenib, and pharmaceutical salts thereof for use in the treatment of enteroviral diseases."

The patent was filed on Oct. 3, 2019, under Application No. ...